期刊文献+

切断Arantius韧带暴露左肝静脉背侧43例体会 被引量:2

Arantius ligament approach to left hepatic vein in partial hepatectomy., experience in 43 patients
原文传递
导出
摘要 目的探讨左肝静脉背侧游离的手术方法。方法在33例尸肝Arantius导管解剖基础上,切断43例患者的Arantius韧带,显露左肝静脉背侧壁并肝外切断左肝静脉。结果43例左肝静脉背侧均被显露并成功切断,术后顺利恢复。结论切断Arantius韧带是显露左肝静脉背侧壁并肝外切断左肝静脉的稳妥方法之一。 Objective To investigate the maneuver of dividing Arantius duet to expose the pos- terior of left hepatic vein. Methods Based on the anatomy of Arantius duct on 33 cadavers, exposure of posterior of left hepatic vein was carried out in 43 patients by dividing the Arantius ligament. Results The posterior of left hepatic vein was dissected to expose the left hepatic vein in 43 patients. The operations and the recovery of the patients were smooth and uneventful. Conclusion Cutting the Arantius ligament allows safe exposure and extrahepatic division of left hepatic vein.
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2012年第8期589-591,共3页 Chinese Journal of Hepatobiliary Surgery
关键词 Arantius导管 左肝静脉 肝切除 Arantius duct Left hepatic vein Hepatectomy
  • 相关文献

参考文献8

  • 1Willioms PI.. Liver anatomy//Grays. GRAYS Anatomy[M]. 39 th ed. , British : Churchill Livingstone, 2004 : 1801.
  • 2Blumgart LH. Liver resection for benign disease and for liverand biliary tumor//Blumgart LH,Fong Y. surgery of the liver and biliary tract[M]. 3th ed. ,Newyork.- Harcourt Health Sci- ences, 2000:1671 -1673.
  • 3Kogure K, Ishizaki M, Nemoto M. Morphogensis of ananom- alous ligamentum venosurm terminating in the superior left he- patic vein in a human liver[J].J Hepatobiliary Pancreat Surg, 2005,12 : 310-313.
  • 4Riceardo L. Liver anatomy//Riccardo lencioni, Dania cioni, Carlo Bartolozzi [M]. Focal liver lesions German: Spring, 2005 : 54.
  • 5Raja D, Abdelwaheb M, Dean R, et al. Anatomy of the liga mentum venosum arantii and its contribution to the left hepatic vein and common trunk control a study on eadaveric livers[J]. J Livers Cells Tissues Organs, 2009,190 :297-300.
  • 6徐庆祥,丁义涛.精确肝切除术的临床应用[J].中华肝胆外科杂志,2009,15(3):166-169. 被引量:12
  • 7Marcel AC, Paulo H, Fabio FM. Anatomic left hepatic triseg mentectomy[J]. Am J Surg, 2005,190:114-117.
  • 8Hisami Ando. A new operation for noncorrectable biliary atre- sia[J]. J MedSci,1999, 3:107-114.

二级参考文献12

  • 1Fan ST. Precise hepatectomy guided by the middle hepatic vein. Hepatobiliary Pancreat Dis Int, 2007,6 : 430- 434.
  • 2Lai PB, Lee KF, Wong J,et al. Techniques for liver resection : a review. Surgeon, 2007,5 : 166-174.
  • 3Shah SA, Cleary SP, Wei AC, et al. Recurrence after liver re section for hepatocellular carcinoma: risk factors, treatment, and outcomes. Surgery, 2007,141 : 330-339.
  • 4Hoffman AL, Wu SS, Obaid AK,et al. Histologic evaluation and treatment outcome after sequential radiofrequency ablation and hepatic resection for primary and metastatic tumors. Am Surg, 2002,68 : 1038-1043.
  • 5Rutkauskas S, Gedrimas V, Pundzius J, et al. Clinical and ana- tomical basis for the classification of the structural parts of liver. Medicina (Kaunas) ,2006,42 : 98-106.
  • 6Sakairi T, Makuuchi M. Identification of the intersegmental or subsegmental plane in the liver with a surgical clip. Surgery, 1991,110:903-904.
  • 7Tralhao JG, Kayal S, Dagher I, et al. Resection of hepatocellular carcinoma: the effect of surgical margin and blood trans-fusion on long term survival. Analysis of 209 consecutive patients. Hepatogastroenterology,2007,54 : 1200-1206.
  • 8Sasaki Y, Yamada T, Tanaka H, et al. Risk of recurrence in a long-term follow-up after surgery in 417 patients with hepatitis B-or hepatitis C-related hepatocellular carcinoma. Ann Surg, 2006,244:771-780.
  • 9Williams R, White J, Croce M,et al. Surgical options in the treatment of hepatocellular carcinoma. Am Surg, 2007,73 : 658-662.
  • 10Kaibori M, Saito T, Matsui Y, et al. A review of the prognos tic factors in patients with recurrence after liver resection for hepatocellular carcinoma. Am J Surg, 2007,193 : 431-437.

共引文献11

同被引文献18

  • 1Filipowicz W,Grosshans H.The liver-specific microRNA miR-122:biology and therapeutic potential[J].Prog Drug Res,2011,67(5):221-238.
  • 2Kutay H,Bai SM,Datta J,et al.Downregulation of miR-122 in the rodent and human hepatocellular carcinomas[J].Cell Biochem,2006,99 (3):671-678.
  • 3Gramantieri L,Ferracin M,Fornari F,et al.Cyclin G1 is a target of miR-122a,a microRNA frequently down-regulated in HCC[J].Cancer Res,2007,67 (13):6092-6099.
  • 4Xu J,Wu C,Che X,et al.Circulating miRNAs miR-21,miR-122,miR-223,in patients with hepatocellular carcinoma or chronic hepatitis[J].MOL Carcinog,2011,50(4):136-142.
  • 5Qi P,Cheng SQ,Wang H,et al.Serum miRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection[J].PloS One,2011,6 (3):e28486.
  • 6Iwai N,Naraba H.Polymorphisms in human pre-miRNAs[J].Biochem Biophys Res Commun,2005,331 (4):1439-1444.
  • 7Yang J,Zhou F,Xu T,et al.Analysis of sequence variations in 59 microRNAs in hepatocellular carcinomas[J].Mutations Research,2008,638(7):205-209.
  • 8Castle JC.SNPs occur in regions with less genomic sequence conservation[J].PLoS One,2011,6 (6):e20660.
  • 9Jazdzewski K,Liyanarachchi S,Swierniak M,et al.Polymorphi mature microRNAs from passenger strand of pre-mir-146a contribute to thyroid cancer[J].Proc Natl Acad Sci USA,2009,106(5):1502-1505.
  • 10Yue C,Wang M,Ding B,et al.Polymorphism of the pre-miR-146a is associated with risk of cervical cancer in a Chinese population[J].Gynecol Oncol,2011,122(1):33-37.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部